Telix Pharmaceuticals Ltd (ASX:TLX) traded atAUD 13.60on 12 June 2026, recording a modest intraday gain of0.97%. The movement occurred in a trading environment where biotechnology equities were closely monitored for pipeline expansion, partnership announcements, and commercialization visibility across oncology-focused platforms.
Cochlear Ltd (ASX:COH) finished higher on 12 June 2026, with shares rising 0.84% to close at AU$103.75. Although the gain was relatively modest compared with some of the day's stronger performers, the move highlights continued investor interest in one of Australia's most recognised healthcare …
Vitrafy Life Sciences Ltd (ASX:VFY) has announced the successful completion of a A$30 million institutional placement, securing support from both existing and new institutional and sophisticated investors. The capital raising follows the company's recent update regarding progress in the US blood market and is …
Vita Life Sciences Ltd (ASX:VLS) attracted investor attention on 12 June 2026 after issuing guidance for the half year ending 30 June 2026. During the afternoon trading session, the company's shares climbed 4.32% to AUD 2.54. The positive market reaction followed management's outlook indicating …
Microba Life Sciences Ltd (ASX:MAP) has emerged as one of the more closely watched healthcare technology companies on the Australian Securities Exchange following its latest capital raising announcement. The microbiome diagnostics and therapeutics company attracted investor attention after securing $5 million through a placement …
Microba Life Sciences Ltd (ASX:MAP) came under significant selling pressure on 12 June 2026, with shares declining 28.57% to close at AU$0.045. The stock traded close to its 52-week low of AU$0.043 during the session, highlighting the challenges currently facing sentiment toward small-cap biotechnology …
TruScreen Group Limited (ASX:TRU) remains one of the more closely followed emerging healthcare technology companies on the Australian Securities Exchange as investors assess its expanding global footprint in cervical cancer screening. The company, which develops AI-enabled real-time cervical cancer screening technology, released a significant …
Alterity Therapeutics Ltd (ASX: ATH) attracted market attention on 12 June 2026 after its shares climbed 14.61% to AUD 0.51. The stock opened at AUD 0.46 and traded within a range of AUD 0.45 to AUD 0.52 during the session, reflecting increased investor activity …
Tetratherix Ltd (ASX:TTX) attracted investor attention on 12 June 2026 after its shares climbed 13.71% to AUD 5.97. The stock opened at AUD 5.40 and reached an intraday high of AUD 6.00 before trading near those levels during the session.
LTR Pharma Ltd (ASX:LTP) attracted investor attention on 12 June 2026 after its shares climbed 16.00% to AUD 0.58. The stock opened at AUD 0.52 and traded within a range of AUD 0.50 to AUD 0.61 during the session, reflecting increased buying activity throughout …